TrialInvestigational new drugs2014

A phase I/II trial of capecitabine combined with peginterferon α-2a in Patients with sorafenib-refractory advanced hepatocellular carcinoma.

Sadahisa Ogasawara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.